{"id":"W4324305894","doi":"10.2337/dc22-2200","title":"Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; U.S. National Library of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Juvenile Diabetes Research Foundation United States of America; Novo Nordisk; Immune Tolerance Network; National Institute of Child Health and Human Development; Abbott Laboratories; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Sanofi; National Institute of Allergy and Infectious Diseases; Pfizer; Bristol-Myers Squibb; Juvenile Diabetes Research Foundation International","keywords":"Abatacept; Medicine; Placebo; Internal medicine; Type 2 diabetes; Diabetes mellitus; Clinical endpoint; Hazard ratio; Immune system; Randomized controlled trial; Immunology; Endocrinology; Gastroenterology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007304963,0.000245781,0.0008298513,0.0001286856,0.00009694981,0.00002183486,0.0001839178,0.0002672454,0.00002122489],"category_scores_gemma":[0.0009092711,0.0001989201,0.0004509798,0.0002979004,0.0001372526,0.000009024535,0.0001411204,0.0001055853,0.00001568062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002949905,"about_ca_system_score_gemma":0.00006674872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004643362,"about_ca_topic_score_gemma":0.00002458298,"domain_scores_codex":[0.9981527,0.0002419588,0.0005019645,0.0004102178,0.0001816702,0.0005114853],"domain_scores_gemma":[0.9987177,0.0003601451,0.0003806627,0.0002739519,0.0001979107,0.00006962765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6983539,0.0002624488,0.2498979,0.0003295369,0.0009967047,0.00000144922,0.001169736,0.001210771,0.04165653,0.00007111481,0.002737182,0.0033127],"study_design_scores_gemma":[0.9602343,0.0009779328,0.0006793129,0.0001008204,0.0001650007,1.160059e-8,0.0008137947,0.001018281,0.0320523,0.0000946687,0.003528927,0.0003346271],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910439,0.004029757,0.000002233285,0.00004244349,0.0004267772,0.003593947,0.0003423985,0.00003704466,0.0004814649],"genre_scores_gemma":[0.9960342,0.0004166465,0.00008346468,0.00002732813,0.00009087635,0.0008642832,0.001639837,0.00004693555,0.0007964279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2618804,"threshold_uncertainty_score":0.8111727,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008513009647779438,"score_gpt":0.2701298714988331,"score_spread":0.2616168618510536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}